$2.35
-0.11-4.47%
At close: Dec 15, 4:00 PM EST
$2.39
0.041.70%
After Hours: 5:40 PM EST
Comments
Loading...
Health Catalyst Stock Guidance | NASDAQ:HCAT | Benzinga
Health Catalyst issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/10/2025 | HCAT | Health Catalyst | Q4 | 2025 | — | — | — | $73.50M | $73.50M | $75.08M | Get Alert |
| 11/10/2025 | HCAT | Health Catalyst | FY | 2025 | — | — | — | $310.00M | $310.00M | $311.18M | Get Alert |
| 08/07/2025 | HCAT | Health Catalyst | FY | 2025 | — | — | — | $310.00M | $310.00M | $334.51M | Get Alert |
| 08/07/2025 | HCAT | Health Catalyst | Q3 | 2025 | — | — | — | $75.00M | $75.00M | $80.56M | Get Alert |
| 05/07/2025 | HCAT | Health Catalyst | FY | 2025 | — | — | — | $335.00M | $335.00M | $334.15M | Get Alert |
| 05/07/2025 | HCAT | Health Catalyst | Q2 | 2025 | — | — | — | $80.50M | $80.50M | $82.93M | Get Alert |
| 02/26/2025 | HCAT | Health Catalyst | FY | 2025 | — | — | — | $335.00M | $335.00M | $336.83M | Get Alert |
| 02/26/2025 | HCAT | Health Catalyst | Q1 | 2025 | — | — | — | $79.00M | $79.00M | $81.88M | Get Alert |
| 11/06/2024 | HCAT | Health Catalyst | FY | 2024 | — | — | — | $305.00M | $311.00M | $307.49M | Get Alert |
| 11/06/2024 | HCAT | Health Catalyst | Q4 | 2024 | — | — | — | $78.00M | $84.00M | $80.69M | Get Alert |
| 08/07/2024 | HCAT | Health Catalyst | FY | 2024 | — | — | — | $304.00M | $312.00M | $307.77M | Get Alert |
| 08/07/2024 | HCAT | Health Catalyst | Q3 | 2024 | — | — | — | $74.50M | $77.50M | $77.99M | Get Alert |
| 05/09/2024 | HCAT | Health Catalyst | FY | 2024 | — | — | — | $304.00M | $312.00M | $308.68M | Get Alert |
| 05/09/2024 | HCAT | Health Catalyst | Q2 | 2024 | — | — | — | $73.50M | $76.50M | $75.55M | Get Alert |
| 02/22/2024 | HCAT | Health Catalyst | FY | 2024 | — | — | — | $304.00M | $312.00M | $324.49M | Get Alert |
| 02/22/2024 | HCAT | Health Catalyst | Q1 | 2024 | — | — | — | $72.50M | $76.50M | $78.99M | Get Alert |
| 01/08/2024 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $293.50M | — | $294.37M | Get Alert |
| 01/08/2024 | HCAT | Health Catalyst | Q4 | 2023 | — | — | — | $72.60M | — | $73.47M | Get Alert |
| 11/02/2023 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $291.00M | $296.00M | $293.78M | Get Alert |
| 11/02/2023 | HCAT | Health Catalyst | Q4 | 2023 | — | — | — | $70.10M | $75.10M | $73.96M | Get Alert |
| 10/27/2023 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $291.00M | $296.00M | $293.78M | Get Alert |
| 10/27/2023 | HCAT | Health Catalyst | Q4 | 2023 | — | — | — | $70.10M | $75.10M | $73.96M | Get Alert |
| 10/27/2023 | HCAT | Health Catalyst | Q3 | 2023 | — | — | — | $73.77M | $73.77M | $72.66M | Get Alert |
| 08/08/2023 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $290.50M | $295.50M | $293.51M | Get Alert |
| 08/08/2023 | HCAT | Health Catalyst | Q3 | 2023 | — | — | — | $70.20M | $74.20M | $72.86M | Get Alert |
| 05/09/2023 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $290.00M | $295.00M | $293.29M | Get Alert |
| 05/09/2023 | HCAT | Health Catalyst | Q2 | 2023 | — | — | — | $70.30M | $74.30M | $72.78M | Get Alert |
| 02/28/2023 | HCAT | Health Catalyst | FY | 2023 | — | — | — | $290.00M | $295.00M | $298.67M | Get Alert |
| 02/28/2023 | HCAT | Health Catalyst | Q1 | 2023 | — | — | — | $70.30M | $72.30M | $71.50M | Get Alert |
| 11/08/2022 | HCAT | Health Catalyst | FY | 2022 | — | — | — | $274.00M | $276.00M | $273.93M | Get Alert |
| 11/08/2022 | HCAT | Health Catalyst | Q4 | 2022 | — | — | — | $66.90M | $68.90M | $68.44M | Get Alert |
| 08/04/2022 | HCAT | Health Catalyst | FY | 2022 | — | — | — | $271.50M | $275.50M | $290.98M | Get Alert |
| 08/04/2022 | HCAT | Health Catalyst | Q3 | 2022 | — | — | — | $65.30M | $68.30M | $74.61M | Get Alert |
| 05/10/2022 | HCAT | Health Catalyst | FY | 2022 | — | — | — | $287.80M | $292.80M | $290.68M | Get Alert |
| 05/10/2022 | HCAT | Health Catalyst | Q2 | 2022 | — | — | — | $68.00M | $71.00M | $70.97M | Get Alert |
| 03/01/2022 | HCAT | Health Catalyst | FY | 2022 | — | — | — | $287.80M | $292.80M | $291.45M | Get Alert |
| 03/01/2022 | HCAT | Health Catalyst | Q1 | 2022 | — | — | — | $64.00M | $67.00M | $68.27M | Get Alert |
FAQ
Q
What is the most recent guidance for Health Catalyst (HCAT)?
A
There have been no specific sales or earnings guidance reported for Health Catalyst in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved